ReviewFrontiers in surgery2026
Port-site metastases after diagnostic laparoscopy in advanced ovarian cancer: a case report and a systematic review of the literature.
Review in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diagnostic laparoscopy is widely used in advanced ovarian cancer to assess resectability and avoid futile laparotomies. However, concerns persist regarding the risk of port-site metastases (PSM), a complication that remains poorly characterized, particularly in terms of clinical impact and management. Methods: We report a case of late-onset giant port-site metastasis occurring after diagnostic laparoscopy in a patient with advanced high-grade serous ovarian cancer. In addition, we conducted a systematic review of the literature according to PRISMA guidelines, including studies reporting PSM after laparoscopy in advanced ovarian cancer. Data on incidence, risk factors, surgical techniques, oncologic outcomes, and management strategies were extracted and analyzed. Results: The reported case illustrates an uncommon but clinically challenging presentation of delayed, rapidly progressive PSM that ultimately precluded surgical management. The systematic review included five eligible studies and revealed a wide variability in PSM incidence, ranging from 1.18% to 46.7%, depending on detection method and study design. Advanced FIGO stage, large-volume ascites, extensive peritoneal disease, and institutional expertise emerged as the main risk factors. Importantly, PSM did not appear to independently affect overall survival, acting instead as a surrogate marker of aggressive disease biology. Routine port-site resection achieved effective local control but was associated with a significantly increased risk of wound-related morbidity, without a demonstrated survival benefit. Conclusions: PSM following diagnostic laparoscopy in advanced ovarian cancer are more frequent than clinically appreciated when histologically assessed but do not appear to adversely influence prognosis beyond underlying disease burden. Routine port-site excision should be carefully weighed against its associated morbidity. Diagnostic laparoscopy remains an oncologically safe and cost-effective tool when appropriately performed in specialized centers, and its benefits outweigh the risks when integrated into a standardized surgical pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.